Skip to main content

Advertisement

Log in

Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD)

  • Published:
AGE Aims and scope Submit manuscript

Abstract

Physiological stress response and oxidative damage are factors for aging processes and, as such, are thought to contribute to neovascular age-related macular degeneration (AMD). Paraoxonase 1 (PON1) is an enzyme that plays an important role in oxidative stress and aging. We investigated association of DNA sequence variants (SNP) within the upstream regulatory region of the PON1 gene with neovascular AMD in 305 patients and 288 controls. Four of the seven tested SNPs (rs705379, rs705381, rs854573, and rs757158) were more frequently found in AMD patients compared to controls (P = 0.0099, 0.0295, 0.0121, and 0.0256, respectively), and all but one (SNP rs757158) are in linkage disequilibrium. Furthermore, haplotype TGGCCTC conferred protection (odds ratio (OR) = 0.76, (CI) = 0.60–0.97) as it was more frequently found in control individuals, while haplotype CGATGCT increased the risk (OR = 1.55, CI = 1.09–2.21) for AMD. These results were also reflected when haplotypes for the untranscribed and the 5′untranslated regions (5′UTR) were analyzed separately. To assess haplotype correlation with levels of gene expression, the three SNPs within the 5′UTR were tested in a luciferase reporter assay. In retinal pigment epithelium-derived ARPE19 cells, we were able to measure significant differences in reporter levels, while this was not observed in kidney-derived HEK293 cells. The presence of the risk allele A (SNP rs705381) caused an increase in luciferase activity of approximately twofold. Our data support the view that inflammatory reactions mediated through anti-oxidative activity may be relevant to neovascular age-related macular degeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Androutsopoulos VP, Kanavouras K, Tsatsakis AM (2011) Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol 256:418–424

    Article  PubMed  CAS  Google Scholar 

  • AREDS (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119:1439–1452

    Article  Google Scholar 

  • Aviram M (2004) Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med 37:1301–1303

    Article  PubMed  CAS  Google Scholar 

  • Baird PN, Chu D, Guida E, Vu HT, Guymer R (2004a) Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration. Am J Ophthalmol 138:665–666

    Article  PubMed  CAS  Google Scholar 

  • Baird PN, Guida E, Chu DT, Vu HT, Guymer RH (2004b) The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Investig Ophthalmol Vis Sci 45:1311–1315

    Article  Google Scholar 

  • Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134

    Article  PubMed  CAS  Google Scholar 

  • Bird AC (2003) The Bowman lecture. Towards an understanding of age-related macular disease. Eye (Lond) 17:457–466

    Article  CAS  Google Scholar 

  • Brion M, Sanchez-Salorio M, Corton M, de la Fuente M, Pazos B et al (2011) Genetic association study of age-related macular degeneration in the Spanish population. Acta Ophthalmol 89:e12–e22

    Article  PubMed  Google Scholar 

  • Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP et al (2001) Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11:77–84

    Article  PubMed  CAS  Google Scholar 

  • Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444

    Article  PubMed  CAS  Google Scholar 

  • Conley YP, Thalamuthu A, Jakobsdottir J, Weeks DE, Mah T et al (2005) Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 14:1991–2002

    Article  PubMed  CAS  Google Scholar 

  • Deakin SP, James RW (2004) Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci (Lond) 107:435–447

    Article  CAS  Google Scholar 

  • Deangelis MM, Silveira AC, Carr EA, Kim IK (2011) Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol 26:77–93

    Article  PubMed  Google Scholar 

  • Dewan A, Liu M, Hartman S, Zhang SS, Liu DT et al (2006) HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314:989–992

    Article  PubMed  CAS  Google Scholar 

  • Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424

    Article  PubMed  CAS  Google Scholar 

  • Esfandiary H, Chakravarthy U, Patterson C, Young I, Hughes AE (2005) Association study of detoxification genes in age related macular degeneration. Br J Ophthalmol 89:470–474

    Article  PubMed  CAS  Google Scholar 

  • Fisher SA, Abecasis GR, Yashar BM, Zareparsi S, Swaroop A et al (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14:2257–2264

    Article  PubMed  CAS  Google Scholar 

  • Garin MC, James RW, Dussoix P, Blanche H, Passa P et al (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62–66

    Article  PubMed  CAS  Google Scholar 

  • Gotoh N, Yamada R, Matsuda F, Yoshimura N, Iida T (2008) Manganese superoxide dismutase gene (SOD2) polymorphism and exudative age-related macular degeneration in the Japanese population. Am J Ophthalmol 146:146, author reply 146–147

    Article  PubMed  CAS  Google Scholar 

  • Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ et al (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227–7232

    Article  PubMed  CAS  Google Scholar 

  • Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38:592–604

    Article  PubMed  CAS  Google Scholar 

  • Haines JL, Schnetz-Boutaud N, Schmidt S, Scott WK, Agarwal A et al (2006) Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Investig Ophthalmol Vis Sci 47:329–335

    Article  Google Scholar 

  • Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T et al (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38:1173–1177

    Article  PubMed  CAS  Google Scholar 

  • Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ et al (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73–76

    Article  PubMed  CAS  Google Scholar 

  • Hyman L, Schachat AP, He Q, Leske MC (2000) Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118:351–358

    Article  PubMed  CAS  Google Scholar 

  • Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T et al (2001) Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 132:191–195

    Article  PubMed  CAS  Google Scholar 

  • Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617

    Article  PubMed  CAS  Google Scholar 

  • Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE et al (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77:389–407

    Article  PubMed  CAS  Google Scholar 

  • Katta S, Kaur I, Chakrabarti S (2009) The molecular genetic basis of age-related macular degeneration: an overview. J Genet 88:425–449

    Article  PubMed  CAS  Google Scholar 

  • Khandhadia S, Lotery A (2010) Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med 12:e34

    Article  PubMed  Google Scholar 

  • Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N (2000) Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130:769–773

    Article  PubMed  CAS  Google Scholar 

  • Kinnunen K, Petrovski G, Moe MC, Berta A, Kaarniranta K (2012) Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol 90:299–309

    Google Scholar 

  • Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389

    Article  PubMed  CAS  Google Scholar 

  • Kloeckener-Gruissem B, Barthelmes D, Labs S, Schindler C, Kurz-Levin M et al (2011) Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. Investig Ophthalmol Vis Sci 52:4694–4702

    Article  CAS  Google Scholar 

  • Leviev I, James RW (2000) Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 20:516–521

    Article  PubMed  CAS  Google Scholar 

  • Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R et al (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38:1049–1054

    Article  PubMed  CAS  Google Scholar 

  • Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN (1998a) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57–60

    Article  PubMed  CAS  Google Scholar 

  • Mackness B, Mackness MI, Arrol S, Turkie W, Julier K et al (1998b) Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341–349

    Article  PubMed  CAS  Google Scholar 

  • Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J et al (1998c) Paraoxonase and coronary heart disease. Curr Opin Lipidol 9:319–324

    Article  PubMed  CAS  Google Scholar 

  • Maller J, George S, Purcell S, Fagerness J, Altshuler D et al (2006) Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38:1055–1059

    Article  PubMed  CAS  Google Scholar 

  • Maziere C, Maziere JC (2009) Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med 46:127–137

    Article  PubMed  CAS  Google Scholar 

  • Moskvina V, Holmans P, Schmidt KM, Craddock N (2005) Design of case-controls studies with unscreened controls. Ann Hum Genet 69:566–576

    Article  PubMed  CAS  Google Scholar 

  • Mueller JC (2004) Linkage disequilibrium for different scales and applications. Brief Bioinform 5:355–364

    Article  PubMed  CAS  Google Scholar 

  • Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M et al (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107:7395–7400

    Article  PubMed  CAS  Google Scholar 

  • Oshima Y, Ishibashi T, Murata T, Tahara Y, Kiyohara Y et al (2001) Prevalence of age-related maculopathy in a representative Japanese population: the Hisayama study. Br J Ophthalmol 85:1153–1157

    Article  PubMed  CAS  Google Scholar 

  • Pang CP, Baum L, Chan WM, Lau TC, Poon PM et al (2000) The apolipoprotein E epsilon4 allele is unlikely to be a major risk factor of age-related macular degeneration in Chinese. Ophthalmologica 214:289–291

    Article  PubMed  CAS  Google Scholar 

  • Paragh G, Seres I, Balogh Z, Varga Z, Karpati I et al (1998) The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 80:166–170

    Article  PubMed  CAS  Google Scholar 

  • Pauer GJ, Sturgill GM, Peachey NS, Hagstrom SA (2010) Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration. Am J Ophthalmol 149:513–522

    Article  PubMed  CAS  Google Scholar 

  • Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P et al (2005) Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14:3227–3236

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–1431

    Article  PubMed  CAS  Google Scholar 

  • Schmidt S, Hauser MA, Scott WK, Postel EA, Agarwal A et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78:852–864

    Article  PubMed  CAS  Google Scholar 

  • Senti M, Tomas M, Fito M, Weinbrenner T, Covas MI et al (2003) Antioxidant paraoxonase 1 activity in the metabolic syndrome. J Clin Endocrinol Metab 88:5422–5426

    Article  PubMed  CAS  Google Scholar 

  • Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169

    Article  PubMed  CAS  Google Scholar 

  • Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989

    Article  PubMed  CAS  Google Scholar 

  • Swaroop A, Branham KE, Chen W, Abecasis G (2007) Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 16(Spec No. 2):R174–R182

    Article  PubMed  CAS  Google Scholar 

  • Tanimoto S, Tamura H, Ue T, Yamane K, Maruyama H et al (2007) A polymorphism of LOC387715 gene is associated with age-related macular degeneration in the Japanese population. Neurosci Lett 414:71–74

    Article  PubMed  CAS  Google Scholar 

  • Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J et al (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15:2784–2790

    Article  PubMed  CAS  Google Scholar 

  • Weger M, Renner W, Steinbrugger I, Kofer K, Wedrich A et al (2007) Association of the HTRA1–625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol Vis 13:1274–1279

    PubMed  CAS  Google Scholar 

  • Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D et al (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314:992–993

    Article  PubMed  CAS  Google Scholar 

  • Zuercher J, Neidhardt J, Magyar I, Labs S, Moore AT et al (2010) Alterations of the 5′untranslated region of SLC16A12 lead to age-related cataract. Investig Ophthalmol Vis Sci 51:3354–3361

    Article  Google Scholar 

  • Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Marijana Samardzija for help with Excel macros to ease data entry in PHASE. We appreciate the genomic DNA preparations by Esther Glaus. Financial support by a cooperative project grant by the Zurich Center for Integrative Human Physiology (ZIHP) of the University of Zurich, Zurich, Switzerland, is greatly acknowledged. DB was supported by a grant from the Swiss National Foundation (SNF/SSMBS), a grant from the Holcim Foundation, and the Walter and Gertrud Siegenthaler Foundation Zürich, Switzerland.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Barbara Kloeckener-Gruissem or Wolfgang Berger.

Additional information

Barbara Kloeckener-Gruissem and Wolfgang Berger contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 33 kb)

About this article

Cite this article

Oczos, J., Grimm, C., Barthelmes, D. et al. Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD). AGE 35, 1651–1662 (2013). https://doi.org/10.1007/s11357-012-9467-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11357-012-9467-x

Keywords

Navigation